LCG
ELGX

Lisanti Capital Growth’s Endologix Inc ELGX Stock Holding History

Lisanti Capital Growth’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,793
Closed -$846K – 121
2016
Q2 		$846K Buy
+6,793
New +$781K 1.28% 30
2015
Q2 		– Sell
-17,506
Closed -$2.99M – 106
2015
Q1 		$2.99M Buy
+17,506
New +$2.65M 1.7% 9

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Lisanti Capital Growth's ELGX Position: Q3 2016 in Review

Lisanti Capital Growth sold out of Endologix Inc (ELGX) in Q3 2016, closing a stake of 6,793 shares — an estimated $846K sold.

Lisanti Capital Growth first reported a position in ELGX in Q1 2015 and held it in 2 quarters. The position peaked at $2.99M in Q1 2015. 152 funds tracked by Wall St. Rank hold ELGX as of Q3 2016.

  • Lisanti Capital Growth reported no remaining Endologix Inc position as of Q3 2016 after selling out during the quarter.
  • Lisanti Capital Growth sold 6,793 Endologix Inc shares in Q3 2016, an estimated $846K.
  • Lisanti Capital Growth first reported a position in Endologix Inc in Q1 2015 and held it in 2 quarters.
  • Lisanti Capital Growth's Endologix Inc position peaked at $2.99M in Q1 2015.
  • 152 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2016.

Based on Lisanti Capital Growth's 13F filing for Q3 2016, filed 24 Oct 2016.